#bipartisan delaware

[delawarebills]

Delaware House Bill 61: An Act To Amend Title 16 Of The Delaware Code Relating To Drugs Used In Government-Sanctioned Executions.

Introduced in House on Mar 6, 2025.

Summary: This Act creates civil and criminal liability for a corporation or other business organized under the laws of this State that sells, distributes, or dispenses a drug that is used as part of a government-sanctioned execution. Under this Act, the highest-ranking officer of the organization that sells, distribute, or dispenses a drug that the officer knows or should know will be used in any capacity in a government-sanctioned execution is guilty of a class A felony and is subject to a civil penalty of not more than $50,000. If the organization is a corporation, its corporate charter will also be revoked.

Link to bill info: https://www.billsponsor.com/bills/712840/delaware-house-bill-61-session-153

[delawarebills]

Delaware Senate Joint Resolution 1: Directing All Electric Utilities In Delaware That Offer Net Metering To Solar Customers To Continue To Participate In A Cost-Benefit Study And Analysis Of Net Metering, Including Cost Burdens And Cost Shifting, Undertaken By The Delaware Sustainable Energy Utility, And Extending The Reporting Date.

Signed by Governor on Feb 14, 2025.

Summary: Senate Joint Resolution No. 3 was passed by the 152nd General Assembly and signed by the Governor. SJR No. 3 directed all electric utilities in Delaware that offer net metering to solar customers to participate in a cost-benefit study and analysis of net metering in Delaware being undertaken by the Delaware Sustainable Energy Utility to address issues such as cost burdens and cost shifting to non-solar customers. The DESEU was to issue a report by December 31, 2024. However, due to the scope and complexity of the net metering study, the DESEU requires additional time to issue the report. This resolution reinstates the requirements of SJR No. 3 and extends the DESEU's reporting deadline to complete the cost-benefit study and analysis and finalize and issue a report to April 30, 2025.

Link to bill information: https://www.billsponsor.com/bills/629250/delaware-senate-joint-resolution-1-session-153

[delawarebills]

Delaware House Bill 61

An Act To Amend Title 16 Of The Delaware Code Relating To Drugs Used In Government-Sanctioned Executions.

Summary

This Act creates civil and criminal liability for a corporation or other business organized under the laws of this State that sells, distributes, or dispenses a drug that is used as part of a government-sanctioned execution. Under this Act, the highest-ranking officer of the organization that sells, distribute, or dispenses a drug that the officer knows or should know will be used in any capacity in a government-sanctioned execution is guilty of a class A felony and is subject to a civil penalty of not more than $50,000. If the organization is a corporation, its corporate charter will also be revoked.